News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...

Recent Postings



HALOZYME (HALO) Seattle Genetics (SGEN) Pluristem (PSTI) Alder Biopharmaceuticals (ALDR) VANDA (VNDA) CEMPRA (CEMP) Gilead (GILD) CompuGen (CGEN) AERIE PHARMACEUTICALS Rapamune AstraZeneca (AZN) CRISPR Therapeutics (CRSP) Vitae Pharmaceuticals (VTAE) ARGOS (ARGS) Benlysta (belimumab) NANTKWEST (NK) Vertex (VRTX) Human Longevity (HLI) Biogen Idec (BIIB) Endometrial Cancer Agenus (AGEN) SYNTA (SNTA) Galena (GALE) Ionis (IONS) Velcade (bortezomib) INNOVIVA (INVA) ACADIA (ACAD) Sanofi (SNY) Anacor (ANAC) Bellicum (BLCM) Human Genome Sciences (HGSI) Editas (EDIT) MODERNA Roche (RHHBY) Genentech Adaptimmune (ADAP) Amgen (AMGN) Prolor Biotech (PBTH) ADVENTRIX (ANX) Incyte (INCY) Multiple Myeloma GUARDIAN HEALTH Tysabri Array Pharmaceuticals (ARRY) Advaxis (ADXS) TOKAI (TKAOI) ISIS (ISIS) NOVOCURE (NVCR) Illumina (ILMN) Theravance (THRX) RenenxBio (RGNX) IDERA (IDRA) Telaprevir Sanofi-Aventis (SAN) Theravance Bio Pharma (TBPH) Zerenex Abbott Laboratories (ABT) Ocular Therapeutix (OCUL) Sequenom (SQNM) Exelixis (EXEL) Bristol-Myers Squibb (BMY) GlaxoSmithKline (GSK) ImmunoGen (IMGN) ZALTRAP™ Ariad (ARIA) Micromet (MITI) Prosensa (RNA) ARCA (ABIO) Spike Therapeutics (ONCE) Sarepta (SRPT) Mirati Therapeutics (MRTX) Auspex (ASPX) Xoma (XOMA) Ridaforolimus Biocryst (BCRX) ABBVIE (ABBV) Dynavax (DVAX) Jazz Pharmaceuticals (JAZZ) galapagos (GLPG) Intrexon (XON) Ziofpharm (ZIOP) Anadys (ANDS) PTC Therapeutics (PTCT) Alnylam (ALNY) Idenix (IDIX) Sanofi (SNA) Aimmune Therapeutics (AIMT) AGOS (ARGS) Roche (ROCHE) Inovio (INO) Regeneron (REGN) NEKTAR (NKTR)) Herceptin JUNO (JUNO) Revlimid (lenolidamide) KITE (KITE) Agenus (AGEN Dendreon (DNDN) Global Cell Therapeutics (GBT) Intercept (ICPT) Onyx (ONXX) Cytokinetics (CYTK) Trastuzumab-DM1 Merck (MRK) C4 Therapeutics SUNESIS PHARMACEUTICALS (SNSS) SERES THERAPEUTICS (MCRB) OSI (OSIP) Intermune (ITMN) Elan (ELN) REGULUS (RGLS) KERYX (KERX) BIOMARIN (BMRN) Sangamo (SGMO) Valeant Pharmaceuticals International (VRX)